These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6112285)

  • 1. [Hemo- and cardiodynamic changes in arterial hypertension patients as affected by alpha- and beta-adrenergic blockader therapy].
    Zonis BIa
    Kardiologiia; 1981 Mar; 21(3):28-32. PubMed ID: 6112285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic effects of hypotensive agents under adrenergic block in hypertension].
    Shchepotin BM; Kazak LI; Guseva NP; Prisiazhniuk MS
    Kardiologiia; 1981 Mar; 21(3):38-41. PubMed ID: 6112286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a single dose of the alpha-adrenergic blockader, pyrroxan, on cardio- and hemodynamics in healthy persons and in arterial hypertension patients].
    Zonis BIa; Brin VB
    Kardiologiia; 1979 Oct; 19(10):102-4. PubMed ID: 41133
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
    Smirnov GB
    Kardiologiia; 1986 Mar; 26(3):33-6. PubMed ID: 2872358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics].
    Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
    Erina EV; Basishvili NZ
    Kardiologiia; 1978 Mar; 18(3):28-35. PubMed ID: 25351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol].
    Shmidt Iu; Khomut V; Monike V; Bakh Kh; Fliugel' Kh
    Kardiologiia; 1985 Jun; 25(6):110-1. PubMed ID: 2864466
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
    Tepliakov AT; Gavrilova NV; Garganeeva AA
    Klin Med (Mosk); 2003; 81(11):17-21. PubMed ID: 14689703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa; Brin VB
    Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of beta-blockader visken in children with primary arterial hypertension].
    Nadezhdina EA; Vul'fson IN; Ivanitskaia IN; Kurbatov VS; Kupriianova OO
    Kardiologiia; 1976 May; 16(5):71-5. PubMed ID: 7701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
    Ol'binskaia LI; Morozova TE
    Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodynamic effects of adrenergic blocking agents.
    Lund-Johansen P
    Cleve Clin J Med; 1992; 59(2):193-200. PubMed ID: 1350235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiated treatment of the initial stages of hypertension depending on hemo- and cardiodynamic indices].
    Kuznetsov NS
    Klin Med (Mosk); 1982 Mar; 60(3):35-9. PubMed ID: 6123614
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenergic blockade in hypertension.
    Metha J
    JAMA; 1978 Oct; 240(16):1759-60. PubMed ID: 29138
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
    Severova NL
    Vrach Delo; 1983 May; (5):26-30. PubMed ID: 6136127
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined labetalol plus flunarizine treatment for arterial hypertension.
    Bonavita E
    Int J Clin Pharmacol Res; 1984; 4(6):475-80. PubMed ID: 6152439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blocking agents.
    Cruickshank JM
    Lancet; 1980 Jun; 1(8183):1415. PubMed ID: 6104197
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change in the central and regional (brain) hemodynamics in the treatment of hypertension using beta-adrenergic blockaders].
    Erina EV; Basishvili NZ; Elizarova NA; Kheĭmets GI
    Kardiologiia; 1976 Jul; 16(7):82-7. PubMed ID: 10464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regional and central hemodynamic changes during the treatment of hypertension with obsidan, apressin and their combination].
    Erina EV; Ozovko GI
    Kardiologiia; 1981 Mar; 21(3):14-9. PubMed ID: 7230593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.